MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand ...
Waters Corporation WAT has been continuously making new enhancements to gain momentum in the Liquid Chromatography Mass Spectrometry (LC-MS) market. This is evident from the fact that the company ...
Waters Corp.WAT recently announced that its indigenously built ACQUITY UPLC I-Class IVD/Xevo TQ-S micro IVD System has been classified as a U.S. FDA Class I medical device. Moreover, it has secured ...
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly ...
Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback